Cooper Companies (NASDAQ: COO - Get Free Report) and QuidelOrtho (NASDAQ: QDEL - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Profitability This table compares Cooper Companies and QuidelOrtho's net

SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, is proud to share episode 61 of its Science Bytes podcast, highlighting key insights about lowering sepsis rates in the emergency room.

Squarepoint Ops LLC acquired a new position in QuidelOrtho Corporation (NASDAQ: QDEL) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 85,251 shares of the company's stock, valued at approximately $1,493,000. Squarepoint Ops LLC owned 0.12% of QuidelOrtho as of

SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 60 of its Science Bytes podcast, featuring highlights from the 2026 Association for Diagnostics and Laboratory Medicine (ADLM) Annual Conference. Hosted by Stephanie Kleewein, the special episode showcases three presentations addressing some of healthcare's most pressing challenges: delivering faster molecular diagnostic results, improving antibiotic stewardship and accelerating cardiovascular assessment.

QuidelOrtho's 2026 outlook cut highlights deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.

QuidelOrtho's resilient core growth and $50 million cost plan offer support, but China weakness, cash use and heavy debt keep the near-term case cautious.

QuidelOrtho's 31.7% three-month rally meets resilient core growth and cost savings, but China weakness, lower guidance and high debt cloud further gains.

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.

QuidelOrtho Corporation (NASDAQ: QDEL - Get Free Report)'s share price gapped down before the market opened on Friday. The stock had previously closed at $16.32, but opened at $12.67. QuidelOrtho shares last traded at $11.9830, with a volume of 631,070 shares trading hands. Key Stories Impacting QuidelOrtho Here are the key news stories impacting QuidelOrtho

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript